American Association for Cancer Research (AACR), 2023.
سنة النشر:
2023
الوصف:
Table S1. List of lung cancer cell lines and histopathological type used to determine the status of the PARD3. Table S2. List of primers used for cloning, PCR and Sanger sequencing of PARD3. Table S3. List of single nucleotide polymorphisms (SNPs) and variants of unknown biological significance identified in lung cancer cell lines and lung primary tumors tested. Table S4. Clinical and pathological parameters of the NSCLC patients and tumors included in the PARD3 gene alterations screening. Table S5. List of genes selected from those genes that fulfilled the criteria: i) adjusted p
